- Trial watch: Peptide-based vaccines in anticancer therapy2018 | Second Faculty of Medicine
- Chapter Three - Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents2017 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Third Faculty of Medicine
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines2022 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine
- Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants2017 | Publication without faculty affiliation
- Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy2017 | Second Faculty of Medicine, First Faculty of Medicine
- Classification of current anticancer immunotherapies2014 | Second Faculty of Medicine
- Trial watch: Dendritic cell-based anticancer therapy2014 | Second Faculty of Medicine
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice2017 | Second Faculty of Medicine
- Tailor made tumor immunotherapy vaccinePublication without faculty affiliation
- Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry2022 | Faculty of Medicine in Hradec Králové
- Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines +12008 | Faculty of Medicine in Hradec Králové
- Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines2008 | First Faculty of Medicine
- Dendritic Cell-Based Immunotherapy Induces Transient Clinical Response in Advanced Rat Fibrosarcoma - Comparison with Preventive Anti-tumour Vaccination2009 | Second Faculty of Medicine
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | Second Faculty of Medicine
- Virosome: An engineered virus for vaccine delivery2023 | Faculty of Pharmacy in Hradec Králové
- In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients2007 | Second Faculty of Medicine
- High hydrostatic pressure in cancer immunotherapy and biomedicine2018 | Second Faculty of Medicine
- Response to Llibre et al2022 | Third Faculty of Medicine
- Principles and Challenges in anti-COVID-19 Vaccine Development2021 | Second Faculty of Medicine
- Trial watch: Naked and vectored DNA-based anticancer vaccines2015 | Second Faculty of Medicine
- Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs2014 | Second Faculty of Medicine, Central Library of Charles University
- An autologous dendritic cell vaccine promotes anticancer immunity in patients with ovarian cancer with low mutational burden and cold tumors2022 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine
- Maturation of dendritic cells by clinically used immunomodulators2004 | Second Faculty of Medicine
- Maturation of dendritic cells by bacterial immunomodulators2004 | Second Faculty of Medicine
- Dendritic cell vaccines for prostate cancer2007 | Second Faculty of Medicine
- Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype2020 | Second Faculty of Medicine, First Faculty of Medicine
- Trial watch: Dendritic cell (DC)-based immunotherapy for cancer2022 | Second Faculty of Medicine
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death2015 | Second Faculty of Medicine
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | Second Faculty of Medicine